Brenus Pharma Pioneering Cancer Vaccines with €22.2M Investment
Lyon-based Brenus Pharma has garnered €22.2 million in funding to further cancer vaccine development, marking a pivotal moment for the company.This investment underscores the growing confidence in Brenus's innovative approaches,…











